The Biotech Battleground Guide

The Biotech Battleground Guide: From Zero to Clinical Stages is focused on the decisions that truly shape outcomes in early biotech: what matters, what comes next, and what counts as real progress.

Drawing on firsthand experience across academia, pharmaceutical R&D, and the startup investment landscape, the book moves beyond "translation theater" to expose the specific decisions that determine whether a venture advances or stalls. Its core philosophy is pragmatic: success requires reverse-engineering the process, thinking backwards from regulatory and clinical endpoints to define value-driving milestones that align scientific execution with capital logic.

Structured around the three critical battlegrounds—Discovery, Preclinical, and IND-Enabling—the guide equips readers with actionable frameworks for systematic derisking. You'll discover:

• Practical decision maps that link evidence to regulatory requirements and funding catalysts
• Tools to assess readiness without self-deception
• The discipline to stop weak programs before they consume runway
• Frameworks that ensure scientific promise transforms into an operationally sound development plan

Written for academics spinning out their first venture, scientists transitioning into industry, and investors seeking sharper evaluation metrics, this book offers an unvarnished view of the ecosystem. A survival map to understand how the early-stage biotech world really works before you decide to play the game.